HEALTH OF WOMAN. 2017.6(122):81–92; doi 10.15574/HW.2017.122.81

Romashchenko O. V., Grygorenko V. M., Biloholovska V. V., Lebid L. O., Volkov S. S.
SI «Institute of urology of NAMS of Ukraine», Kyiv

Infections of urinary tracts (IUT) occupy a priority place both in the level of their outspread and the emergence of recurrences of the disease in ambulatory and stationary practice of a doctor; they are conditioned by inflammatory process, mostly of bacterial genesis, developed in different anatomic parts of urinary system – from fascia renalis to external urethral opening and often combined with pelvic inflammatory diseases.

Purpose of research: to evaluate the effectiveness of complex therapy of chronic recidivating cystitis in combination with pelvic inflammatory diseases in women of reproductive age.

Materials and Methods. A complex clinical and microbiological examination of 39 women aged from 18 to 39 having chronic reccurent cystitis in combination with pelvic inflammatory diseases in the observation dynamics (before and after the course of anti-inflammatory therapy with the inclusion of Tiflox and probiotic Lactovit Forte) was carried out.

Results. As a result of the carried out research the symptomatic development of chronic reccurent cystitis at the background of latent development of pelvic inflammatory diseases was established. In the etiological spectre of chronic reccurent cystitis there were more often microorganisms (mostly E.coli – 82.1%) in the monoculture of critical and high number of microbs, and in 17 (43.5%) mixt-infection was established. Concordance when establishing Chlamydia (7.7%), Mycoplasmas (5.1%), Ureaplasmas (10.3%), Candida (33.4%), and Gardnerella vaginalis (10.3%) both in the biomaterial from urethra and genitals in comparison with the spectre of clinical characteristics certified the presence of interconnection of urinary and reproductive systems, which has to be considered when conducting complex anti-inflammatory therapy.

Conclusion. Treatment of chronic reccurent cystitis should be conducted considering the heaviness and level of changes in the inflammatory process both from the side of urinary and reproductive systems in a single context. Only after the clinical analysis of all factors in combination it is possible to determine the tactics of treatment of infections of urinary system in women of reproductive age with the prescription of grounded and adequate therapy.

Key words: infections of lower urinary tracts, pelvic inflammatory diseases, women of reproductive age, diagnostics, treatment of acute and chronic recurrent cystitis, Tiflox, Lactovit Forte.

REFERENCES

1. Mazzulli T. 2002. Resistance trends in urinary tract pathogens and impact on management. J Urol. 168(4; 2):1720–2.

2. UVI – nedreurinvдgsinfektioner hos kvinnor. UTI – lower urinary tract infections in females. The Medical Products Agency, Sweden. 2007. 18 (2).

3. Unifikovanyi klinichnyi protokol medychnoi dopomohy «Hostryi neuskladnenyi tsystyt u zhinok» № 816 vid 23 lystopada 2011 r.

4. Bjerklund Johansen TE et al. 2011. Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. Int J Antimicrob Agents. 38 Suppl:64–70. https://doi.org/10.1016/j.ijantimicag.2011.09.009; PMid:22018988

5. Ivanov DD. 2005. Infektsii sechovykh shliakhiv u praktytsi simeinoho likaria. Liky Ukrainy. 1:14–16.

6. Hooton TM et al. 1997. Diagnosis and treatment of uncomplicated urinary trac tinfection. Infect Dis Clin North Am. 11(3):551–81. https://doi.org/10.1016/S0891-5520(05)70373-1

7. Wagenlehner FM et al. 2011. Uncomplicated urinary tract infections. Dtsch ArzteblInt. 108(24):415–23. PMid:21776311 PMCid:PMC3132618

8. Stamm WE, Bergan T, Editor. Urinary tract infections in young men, in Urinary tract infections, 1997. Karger, Basel, Switzerland: 46–7. https://doi.org/10.1159/000061396

9. Hooton TM, Naber KG et al., Editors. 2010,  Prevention of recurrent urogenital tract infections in adult women, in EAU/International Consultation on Urological Infections. European Association of Urology: The Netherlands: 236–239.

10. Foxman B et al. 2001. Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J ClinEpidemiol. 54(7):710–8. https://doi.org/10.1016/S0895-4356(00)00352-8

11. McLellan LK, Hunstad DA. 2016, Nov. Urinary Tract Infection: Pathogenesis and Outlook.Trends Mol Med. 22(11):946–957. https://doi.org/10.1016/j.molmed.2016.09.003; PMid:27692880

12. Nicolle LE. 2014. Urinary tract infections in special populations: diabetes, renal transplant, HIV infection, and spinal cord injury. Infect Dis Clin North Am. 28(1):91–104. https://doi.org/10.1016/j.idc.2013.09.006; PMid:24484577

13. Sinyakova LA. 2002. Gnoynyiy pielonefrit (sovremennaya diagnostika i lechenie). Diss. d-ra med. nauk. M:34–213.

14. Lopatkin NA, Derevyanko II, Nefedova LA. 2000. Etiologicheskaya struktura i lechenie infektsionno-vospalitelnyih oslozhneniy v urologicheskoy praktike. Materialyi Plenuma Rossiyskogo obschestva urologov. Kirov:5–29.

15. Pyitel YuA, Zolotarev II. 1985. Neotlozhnaya urologiya. M, Meditsina:26–45.

16. Karpenko VS, Pereverzev AS. 1976. Klinicheskaya urologiya. K:3–18.

17.Enebaev IU, Boluyants ES. 1989. Kliniko-laboratornaya diagnostika i immunologicheskie osobennosti urogenitalnogo hlamidioza, ureaplazmoza i ih assotsiatsii. Aktualnyie voprosyi besplodnogo braka, obuslovlennogo boleznyami, peredayuschimisya polovyim putem. Sverdlovsk:39–40.

18. Demidov VN, Pyitel YuA, Amosov AV. 1989. Ultrazvukovaya diagnostika v uronefrologii. M, Meditsina:112.

19. Bugrova AA, Abdullaeva SA, Torganova EN. 1999. Osnovnyie svoystva vozbuditelya hlamidioza i ego rol v razvitii infektsiy urogenitalnogo trakta. Zhurnal mikrobiologii, epidemiologii i immunobiologii 4:107–111.

20. Reznichenko HI. 2005. Ratsionalna terapiia vulvovahinitiv zmishanoi etiolohii ta profilaktyka retsydyviv. Ukrainskyi zhurnal dermatolohii, venerolohii, kosmetolohii 1:105–106.

21. Savicheva AM, Bashmakova MA. 1998. Urogenitalnyiy hlamidioz u zhenschin i ego posledstviya. N. Novgorod:3–89.

22. Stamm WE et al. 1993. Management of urinary tract infections in adults. N Engl J Med. 329(18):1328–34. https://doi.org/10.1056/NEJM199310283291808; PMid:8413414

23. Ventskovskiy BM, Tovstanovskaya VA, Yankovskiy DS. 2002. Mikroekologicheskie aspektyi reproduktivnogo zdorovya zhenschinyi i sovremennyie podhodyi k ego podderzhaniyu. Zdorove zhenschinyi 3(11):86–91.

24. Yankovskiy DS. 2005. Mikrobnaya ekologiya cheloveka. Sovremennyie vozmozhnosti ee podderzhaniya i vosstanovleniya mikrofloryi. K, Ekspert LTD:362.

25. Yankovskiy DS. 2003. Sostav i funktsii mikrobiotsenozov razlichnyih biotopov cheloveka. Tekst. Zdorove zhenschinyi 4(16):145–158.

26. Sadeghi-Nejad H, Wasstrman M, Weidner W, Richardsson D, Goldmeier D. 2010. Sexually Transmitted Diseases and sexual function. Journal of Sexual Medicine. 7:389–413. https://doi.org/10.1111/j.1743-6109.2009.01622.x; PMid:20092446

27. Grazziotti A. 2012. October,7–12. Menstrualbleeding:pathophisiologyandcomorbidity. International Federation of Gynecology and Obstetrics World Congress of Gynecologyand Obstetrics. Roma, Italy.

28. Berbic M at all. 2014. Inflammation and endometrial bleeding. Climacteric. 17:47–53. https://doi.org/10.3109/13697137.2014.963964; PMid:25247830

29. Gopchuk EN, Gerasimova TV. 2016. Menstrualnyiy tsikl i ego svyaz s sistemnyim vospaleniem. Zdorove zhenschinyi 3(109):99–102.

30. Potapov VA. 2005. Tifloks: novyiy podhod k lecheniyu smeshannyih infektsiy organov malogo taza u zhenschin. Mistetstvo lIkuvannya 4:86–87.

31. Romashchenko OV, Vozianova SV, Rudenko AV. 2016. Likuvannia zapalnykh zakhvoriuvan orhaniv maloho taza, sprychynenykh mikst-infektsiieiu. Zdorove zhenshchynы 6:34–42

32. Ku JH et al. 2004. Voiding diary for the evaluation of urinary incontinence and lower urinary tract symptoms: prospective assessment of patient compliance and burden. Neurourol Urodyn 23(4):331. https://doi.org/10.1002/nau.20027; PMid:15227650

33. Bradbury SM. 1988. Collection of urine specimens in general practice: to clean or not to clean? J R Coll Gen Pract. 38(313):363–5. PMid:3256648 PMCid:PMC1711498

34. Kunin C. Urinary tract infections, in detection, prevention and management. 1997. Lea &Febiger: Philadelphia.

35. Grabe M, Bjerklund-Johansen TE et al. 2013. Guidelines on Urologiсal Infections. — European Association of Urology.

36. Falagas ME et al. 2009. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a metaanalysis of randomized controlled trials. J Infect. 58(2):91–102. . https://doi.org/10.1016/j.jinf.2008.12.009

37. Gupta K et al. 2007. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med. 167(20):207–12. https://doi.org/10.1001/archinte.167.20.2207; PMid:17998493

38. Lecomte F et al. 1997. Single-dose treatment of cystitis with fosfomycintrometamol (Monuril): analysis of 15 comparative trials on 2,048 patients. Giorn It Ost Gin. 19:399–404.

39. Nicolle LE. 2000. Pivmecillinam in the treatment of urinary tract infections. J AntimicrobChemother. 46;1:35-9; discussion 63–5. https://doi.org/10.1093/jac/46.suppl_1.35

40. Pasiechnikov SP. 2011. Urolohiia: diiuchi protokoly nadannia medychnoi dopomohy: 488–489.